4th Quarter - Report

TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC

Period 4th Quarter 2020 Filed Jan 21, 2021 Signed by Dolly Judge, Vice President, U.S. Government Affairs

Official filing
Firm
TEVA PHARMACEUTICALS USA, INC.
Client
TEVA PHARMACEUTICALS USA INC
Income
—
Expenses
$610,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Legislation and proposals related to the COVID-19 crisis; HR 3199-Terminating the Extension of Rights Misappropriated Act of 2019; S.64-Preserve Access to Affordable Generic & Biosimilars Act; HR 1499-Protecting Consumer Access to Generic Drugs Act; HR 1344-Competitive Drugs Act of 2019; HR 938-Bringing Low Cost Options & Competition While Keeping Incentives for New Generics Act ("BLOCKING Act"); HR 1506-Fair & Immediate Release of Generic Drugs Act; HR 1520-Purple Book Continuity Act; HR 1503-Orange Book Transparency Act; S.344/HR 990-Hatch-Waxman Integrity Act; Stronger Patents Act; S.1895-Lower Health Care Costs Act; S. 2543-Prescription Drug Pricing Reduction Act; HR 3-Elijah E Cummings Lower Drug Costs Now Act; Administration review of drug pricing policies; Proposals to improve pharmaceutical supply-chain vlunterabilities; HR 4597-Acting to Cancel Copays & Ensure Substantial Savings for Biosimilars (ACCESS) Act; HR 4455-Bolstering Innovative Options to Save Immediately on Medicines (BIOSIMS) Act; HR 6179-Lowering Costs for Taxpayers & Medicare Seniors with Biosimilars; HR 4629-Star Ratings for Biosimilars Act.

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA Inc., has an interest in the issues listed.

LobbyistCovered position, as disclosed
MICHAEL BRZICA —
DOLLY A JUDGE —
BEENA S PATEL New —
COLMAN BRENDAN RAGAN —

Contacted: Natl Security Council (NSC); SENATE; White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Bills named: S. 2543 (116th), H.R. 4597 (116th), S. 1895 (116th), S. 64 (116th), H.R. 1520 (116th), H.R. 1506 (116th), S. 344 (116th), H.R. 1503 (116th), H.R. 3199 (116th), H.R. 6179 (116th), H.R. 3 (116th), H.R. 938 (116th), H.R. 990 (116th), H.R. 4629 (116th), H.R. 1344 (116th), H.R. 4455 (116th), H.R. 1499 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.